Atracurium Besylate - CAS 64228-81-5
Catalog number: 64228-81-5
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
Atracurium Besylate is a neuromuscular blocking agent with ED95 of 0.2 mg/kg.
Publictions citing BOC Sciences Products
  • >> More
Norlaudanosine HCl
1.Sugammadex at both high and low doses does not affect the depth of anesthesia or hemodynamics: a randomized double blind trial.
Fassoulaki A1, Chondrogiannis K2, Staikou C2. J Clin Monit Comput. 2016 Feb 19. [Epub ahead of print]
Previous studies have shown that sugammadex decreases the anesthetic depth when administered to reverse the neuromuscular blockade produced by rocuronium/vecuronium. The aim of the present study was to investigate the effect of sugammadex alone on anesthetic depth and hemodynamics. Sixty patients scheduled for abdominal surgery participated in the study. Anesthesia was induced with thiopental/fentanyl and maintained with N2O/oxygen and sevoflurane concentrations adjusted to maintain Entropy and Bispectral Index (BIS) values between 40 and 50. Cis-atracurium 0.2 mg/kg was administered for neuromuscular blockade which was monitored with a TOF-Watch® SX acceleromyograph. State entropy (SE), response entropy (RE), Bispectral Index (BIS), systolic (SAP) and diastolic blood pressure (DAP), heart rate (HR), SpO2, end-tidal CO2 and sevoflurane concentrations were recorded every 3 min intraoperatively. Sugammadex 2 mg/kg (Group-2), 4 mg/kg (Group-4) or 16 mg/kg (Group-16) was given intravenously when a count of two responses of the train-of-four (TOF) or a post-tetanic count (PTC) 1-3 appeared or when no response at all (PTC = 0) was observed, respectively.
2.Esmolol reduces anesthetic requirements thereby facilitating early extubation; a prospective controlled study in patients undergoing intracranial surgery.
Asouhidou I1, Trikoupi A2. BMC Anesthesiol. 2015 Nov 28;15:172. doi: 10.1186/s12871-015-0154-1.
BACKGROUND: Adequate cerebral perfusion pressure with quick and smooth emergence from anesthesia is a major concern of the neuroanesthesiologist. Anesthesia techniques that minimize anesthetic requirements and their effects may be beneficial. Esmolol, a short acting hyperselective β-adrenergic blocker is effective in blunting adrenergic response to several perioperative stimuli and so it might interfere in the effect of the anesthetic drugs on the brain. This study was designed to investigate the effect of esmolol on the consumption of propofol and sevoflurane in patients undergoing craniotomy.
3.Recommendations and Low-Technology Safety Solutions Following Neuromuscular Blocking Agent Incidents.
Graudins LV1, Downey G, Bui T, Dooley MJ. Jt Comm J Qual Patient Saf. 2016 Feb;42(2):86-91.
BACKGROUND: Neuromuscular blocking agents (NMBs) are high-risk medications used to facilitate endotracheal intubation and artificial ventilation. In an incident at a metropolitan tertiary referral and teaching public hospital in Australia, a neurosurgical patient became unresponsive at the start of surgery. It was determined that cisatracurium was administered in error in place of midazolam; the patient was ventilated and the emergency surgery continued. Two additional non-operating room (OR) drug-swap cases involving cisatracurium were reported within 12 months of this event, resulting in a comprehensive review of NMB safety.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related nAChR Products

CAS 15585-43-0 RJR-2403

(CAS: 15585-43-0)

At concentrations up to 1 mM, RJR-2403 does not significantly activate nAChRs in PC12 cells, muscle type nAChRs or muscarinic receptors. Dose-response curves fo...

CAS 2468-21-5 Catharanthine

(CAS: 2468-21-5)

Catharanthine inhibits nicotinic receptor mediated diaphragm contractions with IC50 of 59.6 μM.

(CAS: 439608-12-5)

CP-810123 is a novel alpha 7 nAChR agonist with potential treatment for cognitive deficits associated with psychiatric or neurological conditions including schi...

(CAS: 357425-02-6)

CP-601927 is a CNS-penetrant, high affinity, and selective nicotinic acetylcholine receptor (nAChR) agonist.

CAS 64228-81-5 Atracurium Besylate

Atracurium Besylate
(CAS: 64228-81-5)

Atracurium Besylate is a neuromuscular blocking agent with ED95 of 0.2 mg/kg.

CAS 220662-95-3 RJR-2403 oxalate

RJR-2403 oxalate
(CAS: 220662-95-3)

A neuronal nicotinic receptor agonist, showing high selectivity for the α4β2 subtype (Ki values are 26 and 36000 nM for α4β2 and α7 receptors respectively). Act...

AZD 0328
(CAS: 220099-91-2)

AZD 0328 is a potent α7 NNR/5HT3 receptor agonist. AZD0328 led to a significant increase in cortical dopamine release in awake rodents and improved both conditi...

CAS 550999-74-1 Encenicline, HCl salt

Encenicline, HCl salt
(CAS: 550999-74-1)

EVP-6124, its alpha-7 nicotinic acetylcholine receptor agonist, possesses a novel mechanism not previously seen in the scientific community: it acts as a co-ago...

CAS 156223-05-1 GTS-21

(CAS: 156223-05-1)

GTS-21, also known as DMBX-A, is a derivative of the natural product anabaseine that acts as a partial agonist at neural nicotinic acetylcholine receptors. It b...

(CAS: 639489-84-2)

Bradanicline acts as a partial agonist at the α7 subtype of the neural nicotinic acetylcholine receptors. It showed cognitive enhancing effects in animal studie...

CAS 7187-66-8 Trimethaphan

(CAS: 7187-66-8)

Trimetaphan camsilate can counteract cholinergic transmission at the ganglion type of nicotinic receptors of the autonomic ganglia and this lead to block both t...

CAS 1508-76-5 Procyclidine hydrochloride

Procyclidine hydrochloride
(CAS: 1508-76-5)

The hydrochloride salt form of Procyclidine which has been found to be a muscarinic antagonist that could be effective against Parkinson's disease and some rela...

(CAS: 677306-35-3)

Facinicline is a partial agonist of the nicotinic alpha-7 (α7) receptor. It is used for the oral treatment of Alzheimer's. It was being co-developed by Roche an...

Bradanicline hydrochloride
(CAS: 1111941-90-2)

Bradanicline hydrochloride is Alpha-7 Nicotinic Receptor Agonist. It showed cognitive enhancing effects in animal studies, and was being developed as a potentia...

CAS 50700-72-6 Vecuronium Bromide

Vecuronium Bromide
(CAS: 50700-72-6)

Vecuronium bromide (Norcuron) is a muscle relaxant in the category of non-depolarizing blocking agents. Vecuronium bromide is indicated as an adjunct to general...

CAS 55-97-0 Hexamethonium Bromide

Hexamethonium Bromide
(CAS: 55-97-0)

Hexamethonium Bromide is a selective antagonist of neuronal-type nicotinic AChR in ganglia.

CAS 799279-80-4 Sofinicline

(CAS: 799279-80-4)

Sofinicline is a novel nicotinic acetylcholine receptor agonist under development of Abbott Laboratories. Till now, no development was reported for Phase-II for...

CAS 52-62-0 Pentolinium Tartrate

Pentolinium Tartrate
(CAS: 52-62-0)

Pentolonium tartrate is the tartrate salt form of pentolinium, which is a ganglionic blocking agent and acts as a nicotinic acetylcholine receptor antagonist. I...

CAS 134-63-4 α-Lobeline Hydrochcloride

α-Lobeline Hydrochcloride
(CAS: 134-63-4)

The hydrochloride salt form of α-Lobeline, a nicotinic receptor agonist, could be used against asphyxia and respiratory failure.

CAS 96946-42-8 Cisatracurium besylate

Cisatracurium besylate
(CAS: 96946-42-8)

Cisatracurium besylate is a neuromuscular blocking agent that is used in liver transplant patient with safety. Cisatracurium besylate is also an enantiomer of A...

Chemical Structure

CAS 64228-81-5 Atracurium Besylate

Quick Inquiry

Verification code

Featured Items